PERCEIVE-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID

Abroad (travel likely)Recruiting

Conditions

Long COVID

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Menzies Insititute for Medical Research, Hobart, Tasmania, Australia
Contact: Study coordinator (Quan Huynh, PhD) · quan.huynh@utas.edu.au · +61 03 8532 1833
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Contact: Study coordinator (Tom Marwick, MD, MPH, PhD) · tom.marwick@baker.edu.au · +61385321550

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Taurine Supplementation in Long COVID

Long COVID

Abroad (travel likely)RecruitingPHASE2, PHASE3

Edmonton, Canada · Vancouver, Canada

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

Long COVID · Sars-CoV-2 Infection · Coronavirus Infections

Abroad (travel likely)RecruitingPHASE3

Tucson, United States · Los Angeles, United States

Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic

Covid19 · Long COVID

Abroad (travel likely)Recruiting

Montreal, Canada

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

Long COVID-19 Syndrome · COVID 19 · Noncommunicable Disease

Abroad (travel likely)Recruiting

Bogotá, Colombia